252 related articles for article (PubMed ID: 18705817)
1. Dual renin-angiotensin system blockade: on the target.
Robles NR
Int J Clin Pract; 2008 Aug; 62(8):1134-6. PubMed ID: 18705817
[No Abstract] [Full Text] [Related]
2. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
Singh A
Nephrol Dial Transplant; 2006 Mar; 21(3):830-1. PubMed ID: 16278255
[No Abstract] [Full Text] [Related]
3. Combination renin-angiotensin system blockade in hypertension.
Doulton TW; Macgregor GA
Kidney Int; 2005 Oct; 68(4):1898. PubMed ID: 16164672
[No Abstract] [Full Text] [Related]
4. Dual renin-angiotensin system blockade in heart failure.
McMurray JJ; Granger CB; Ostergren J; Yusuf S; Pfeffer MA; Swedberg K
J Am Coll Cardiol; 2009 Jul; 54(3):278; author reply 279-80. PubMed ID: 19589444
[No Abstract] [Full Text] [Related]
5. Dual renin-angiotensin system blockade and kidney disease.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Pfeffer MA
J Am Coll Cardiol; 2009 Jul; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
[No Abstract] [Full Text] [Related]
6. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
Hollenberg NK
Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
[TBL] [Abstract][Full Text] [Related]
7. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Hirsch S
Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
[No Abstract] [Full Text] [Related]
8. Renin inhibition: what are the clinical perspectives?
Hollenberg NK
Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
[TBL] [Abstract][Full Text] [Related]
9. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL; Townsend RR
J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
Zaffanello M; Franchini M; Fanos V
Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
[TBL] [Abstract][Full Text] [Related]
11. Rationale for combining blockers of the renin-angiotensin system.
Azizi M; Wuerzner G
Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
[TBL] [Abstract][Full Text] [Related]
12. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
13. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
Mann JF; McClellan WM; Kunz R; Ritz E
Nephrol Dial Transplant; 2006 Sep; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
[No Abstract] [Full Text] [Related]
14. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
Ku E; Park J; Vidhun J; Campese V
Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
[No Abstract] [Full Text] [Related]
15. [Blocking the renin-angiotensin system in chronic kidney disease].
Segura J
Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
[No Abstract] [Full Text] [Related]
16. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Dabrowski R; Szwed H
Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
[No Abstract] [Full Text] [Related]
17. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
Fomin VV; Moiseev SV; Mukhin NA
Ter Arkh; 2007; 79(10):86-91. PubMed ID: 18154154
[No Abstract] [Full Text] [Related]
18. RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice.
Pitt B
Heart; 2009 Aug; 95(15):1205-8. PubMed ID: 19401281
[No Abstract] [Full Text] [Related]
19. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
Berl T
Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
[No Abstract] [Full Text] [Related]
20. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
Ram CV; Deedwania PC
Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
